|Day Low/High||35.40 / 35.80|
|52 Wk Low/High||28.00 / 43.60|
Investors in Natus Medical Inc. saw new options become available this week, for the July 2018 expiration.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALOT, BOOM, BWA, DAR, EHTH, ESRT, ETR, FNGN, FOE, FPO, FSS, GGG, KKR, KRA, MSCC, TOT, TZOO, WMAR Downgrades: BABY, CREG, DEPO, ETH, EXPE, GNRC, SPOK, TDC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Natus Medical Incorporated (NASDAQ: BABY)...
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Natus Medical Incorporated ("Natus") (NASDAQ:BABY) between...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.